Shenzhen Hwagen Pharmaceutical

CAS 61477-40-5

Chemistry, 9 End Use API, 29 Related Intermediates

Manufacturers/Suppliers

9 Suppliers

9 Suppliers

Also known as: 61477-40-5, (3r)-3-aminobutan-1-ol, (r)-3-amino-1-butanol, (3r)-3-amino-1-butanol, (r)-3-amino-butan-1-ol, 1-butanol, 3-amino-, (r)-

Molecular Formula

C₄H₁₁NO

Molecular Weight

89.14 g/mol

InChI Key

AGMZSYQMSHMXLT-SCSAIBSYSA-N

1 2D Structure

CAS 61477-40-5

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(3R)-3-aminobutan-1-ol

2.1.2 InChI

InChI=1S/C4H11NO/c1-4(5)2-3-6/h4,6H,2-3,5H2,1H3/t4-/m1/s1

2.1.3 InChI Key

AGMZSYQMSHMXLT-SCSAIBSYSA-N

2.1.4 Canonical SMILES

CC(CCO)N

2.1.5 Isomeric SMILES

C[C@H](CCO)N

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 61477-40-5

2. (3r)-3-aminobutan-1-ol

3. (r)-3-amino-1-butanol

4. (3r)-3-amino-1-butanol

5. (r)-3-amino-butan-1-ol

6. 1-butanol, 3-amino-, (r)-

7. R-3-amino-1-butanol

8. (r,s)-3-amino-butan-1-ol

9. Dtxsid30432476

10. Bcp01279

11. Zinc2530278

12. Am9719

13. Mfcd13184351

14. Akos015854097

15. Cs-w013746

16. Gs-3850

17. C3441

18. A15693

19. W-204235

2.3 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₄H₁₁NO
Molecular Weight	89.14 g/mol
XLogP3	-0.6
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	2
Rotatable Bond Count	2
Exact Mass	89.084063974 g/mol
Monoisotopic Mass	89.084063974 g/mol
Topological Polar Surface Area	46.2 Å²
Heavy Atom Count	6
Formal Charge	0
Complexity	30.7
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

China

Virtual Booth

Digital Content

1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-...

PDF Supplier PDF

URL Supplier Web Content

CAS Number

1335210-23-5

End Use API

Dolutegravir Sodium

About the Company

Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leader...

Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leadership of a “National 1000 Talents Program” expert. By leveraging its core competency in chiral synthesis, enzymatic catalysis and continuous flow micro reactor, HwaGen Pharmaceutical is dedicated to development and manufacturing of specialty and niche intermediates and APIs covering various therapeutic areas including oncology, antiviral and respiratory, delivering high value-added and affordable products for global pharmaceutical industry. Equipments for Analysis & Test include Tabletop NMR, LC-MS, GC, HPLC etc.

ASK
US